2 not yet recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 2 |
| Phase 2 | 2 | Not yet recruiting 2 |
| Not applicable | 1 | Withdrawn 1 |
Follow Placebo IV administration: new trials by email Literature Review of Placebo IV administration trials Research Report on Placebo IV administration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms IV infusion using an isolated, placental, mesenchymal stem cell derived EVs, Placebo IV administration - COVID-19 | Phase 1 / Phase 2 | Not yet recruiting | Kimera Labs Inc. | 64 | 2027-01-01 | 2026-06-24 |
| The Effect of Dexamethasone on Short Term Patient Response: IV vs Oral Administration Dexamethasone IV injection, Dexamethasone Capsule, Placebo IV administration - Post Operative Pain, Acute, Periodontitis | Phase 1 / Phase 2 | Not yet recruiting | The University of Texas Health Science Center at San Antonio | 40 | 2026-10-01 | 2026-09-21 |
| Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery Ofiramev® (IV Acetaminophen), Placebo IV administration - Post-thoracotomy Pain Syndrome | Not applicable | Withdrawn | The University of Texas Medical Branch, Galveston | 2018-06-01 | 2019-02-05 |
COVID-19 (1) · Pain, Postoperative (1) · Periodontitis (1)
Kimera Labs Inc. (1) · The University of Texas Health Science Center at San Antonio (1) · The University of Texas Medical Branch, Galveston (1)
United States (1)
Angela Paliaologou-Gallis, DDS (1) · Dr. Azza Halim, MD (1) · Ikenna Okereke, MD (1) · Mostafa Shehabeldin, DDS, MS, PhD (1)